Search research articles
Contact Us
Filters
Showing results (51-60 of 91) with videos related to
Page
of 10
Sort By:
Clinical Immunology (Orlando, Fla.)
|
February 5, 2022
Subcutaneous Gammanorm® by pump or rapid push infusion: Impact of the device on quality of life in adult patients with primary immunodeficiencies
Klaus Warnatz, Stephen Jolles, Carlo Agostini, et al.
Journal of Leukocyte Biology
|
October 16, 2024
A new model measuring bacterial phagocytosis and phagolysosomal oxidation in humans using the intradermal injection of methylene blue-labeled Escherichia coli
George B Collins, Jhonatan de Souza Carvalho, Sandali C Jayasinghe, et al.
British Journal of Clinical Pharmacology
|
March 23, 2026
Population pharmacokinetic/pharmacodynamic modelling to evaluate favipiravir in combination with lopinavir-ritonavir in patients with COVID-19
Akosua A Agyeman, Laura Buggiotti, Li-An K Brown, et al.
The Lancet. Infectious Diseases
|
August 19, 2021
Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials
Ed Moran, Tim Cook, Anna L Goodman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 15, 2017
Neutrophil Activation and Enhanced Release of Granule Products in HIV-TB Immune Reconstitution Inflammatory Syndrome
Justine K Nakiwala, Naomi F Walker, Collin R Diedrich, et al.
Iscience
|
March 2, 2026
Extensive evolution and T cell escape by SARS-CoV-2 in a 2.5-year persistent infection of an immunocompromised host
José Afonso Guerra-Assunção, Ruairi McErlean, Katie Townsend, et al.
Journal of Clinical Immunology
|
May 6, 2023
Persistent SARS-CoV-2 PCR Positivity Despite Anti-viral Treatment in Immunodeficient Patients
Michele Chan, Me Me Nay Linn, Thomas O'Hagan, et al.
The Journal of Infectious Diseases
|
April 1, 2025
A viro-immunological model to characterize the antiviral effect of molnupiravir in SARS-CoV-2-infected outpatients: implication for treatment duration
Bach Tran Nguyen, Julie Bertrand, Akosua A Agyeman, et al.
Frontiers in Immunology
|
August 28, 2020
Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea
Cornelia M van Schewick, Christina Nöltner, Svenja Abel, et al.
The Journal of Clinical Investigation
|
September 11, 2025
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2
Shadisadat Esmaeili, Katherine Owens, Ugo Avila-Ponce de Leon, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 91) with videos related to
Sort By:
Page
of 10
Clinical Immunology (Orlando, Fla.)
|
February 5, 2022
Subcutaneous Gammanorm® by pump or rapid push infusion: Impact of the device on quality of life in adult patients with primary immunodeficiencies
Klaus Warnatz, Stephen Jolles, Carlo Agostini, et al.
Journal of Leukocyte Biology
|
October 16, 2024
A new model measuring bacterial phagocytosis and phagolysosomal oxidation in humans using the intradermal injection of methylene blue-labeled Escherichia coli
George B Collins, Jhonatan de Souza Carvalho, Sandali C Jayasinghe, et al.
British Journal of Clinical Pharmacology
|
March 23, 2026
Population pharmacokinetic/pharmacodynamic modelling to evaluate favipiravir in combination with lopinavir-ritonavir in patients with COVID-19
Akosua A Agyeman, Laura Buggiotti, Li-An K Brown, et al.
The Lancet. Infectious Diseases
|
August 19, 2021
Persistent SARS-CoV-2 infection: the urgent need for access to treatment and trials
Ed Moran, Tim Cook, Anna L Goodman, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
November 15, 2017
Neutrophil Activation and Enhanced Release of Granule Products in HIV-TB Immune Reconstitution Inflammatory Syndrome
Justine K Nakiwala, Naomi F Walker, Collin R Diedrich, et al.
Iscience
|
March 2, 2026
Extensive evolution and T cell escape by SARS-CoV-2 in a 2.5-year persistent infection of an immunocompromised host
José Afonso Guerra-Assunção, Ruairi McErlean, Katie Townsend, et al.
Journal of Clinical Immunology
|
May 6, 2023
Persistent SARS-CoV-2 PCR Positivity Despite Anti-viral Treatment in Immunodeficient Patients
Michele Chan, Me Me Nay Linn, Thomas O'Hagan, et al.
The Journal of Infectious Diseases
|
April 1, 2025
A viro-immunological model to characterize the antiviral effect of molnupiravir in SARS-CoV-2-infected outpatients: implication for treatment duration
Bach Tran Nguyen, Julie Bertrand, Akosua A Agyeman, et al.
Frontiers in Immunology
|
August 28, 2020
Altered Microbiota, Impaired Quality of Life, Malabsorption, Infection, and Inflammation in CVID Patients With Diarrhoea
Cornelia M van Schewick, Christina Nöltner, Svenja Abel, et al.
The Journal of Clinical Investigation
|
September 11, 2025
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2
Shadisadat Esmaeili, Katherine Owens, Ugo Avila-Ponce de Leon, et al.
Page
of 10